Work

Rational Targeted Therapeutics for Double-Hit Lymphoma

Year: 2019

Type: editorial

Abstract: Due to simultaneous activation of these driver oncogenes, DHLs are among the most aggressive and chemoresistant lymphoma subtypes with minimal treatment options ""Double-hit lymphomas with MYC and BCL2 translocations can be effectively treated by combined targeting of the driver oncogenes".

Source: International Journal of Hematologic Oncology

DOI: 10.2217/ijh-2019-0009

Authors: Nancy G Azizian, Yuanhui Liu, Lan V Pham, Yulin Li

Institutions: Houston Methodist, Weill Cornell Medicine, Houston Methodist Research Institute, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $1,415